Merck obesity drug sees success in late-stage trials

04/1/2008 | MSNBC · Boston Globe (tiered subscription model), The

Merck & Co. says its experimental obesity drug taranabant helped patients in a late-stage clinical trial lose more than twice as much weight as participants who took a placebo. The pharmaceutical company says it will not include higher doses of the drug in future studies, however, because of increased rates of nausea and psychiatric side effects.

View Full Article in:

MSNBC · Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ